SILICOFCM: In Silico trials for drug tracing the effects of sarcomeric protein mutations leading to familial cardiomyopathy

SILICOFCM: In Silico trials for drug tracing the effects of sarcomeric protein mutations leading to familial cardiomyopathy Website

Status: Finished Start:

01/06/2018

End:

28/02/2022

Primary tabs

• BSC Principal Investigator (active tab)
• Overview